Suninflam Ltd. – Trademark Portfolio

Entity Type: 03

Suninflam Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SUNINFLAM.

Room 612, Building No. 1 Shenzhen Institute of Adv

No. 299, Huimao Road, Loucun Community, Xinhu Stre Guangming District, Shenzhen City 518000 Guangdong Province

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SUNINFLAM
SUNINFLAM
Registered 2024

Trademark Classifications

Suninflam Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Suninflam Ltd. have?

Suninflam Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Suninflam Ltd. file in?

Suninflam Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Suninflam Ltd.'s most well-known trademarks?

Suninflam Ltd.'s registered trademark portfolio includes well-known marks such as SUNINFLAM. These are among 1 currently registered trademark in the portfolio.

What is Suninflam Ltd.'s trademark registration success rate?

Suninflam Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.